TP53BP1 and cancer: Collectively, our findings report a previously unidentified regulatory mechanism for PRMT5 methyltransferase activity through Src kinase-induced Y324 phosphorylation, and the involvement of PRMT5 in NHEJ repair pathway through regulation of 53BP1 stability, which can be targeted for cancer treatment.